MT, R., KA, M., M, S., JL, K., CF, M., & RM, B. (2023). Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations. Pharmacology, biochemistry, and behavior, 229, 173592. https://doi.org/10.1016/j.pbb.2023.173592
Chicago Style (17th ed.) CitationMT, Rodriguez, McLaurin KA, Shtutman M, Kubinak JL, Mactutus CF, and Booze RM. "Therapeutically Targeting the Consequences of HIV-1-associated Gastrointestinal Dysbiosis: Implications for Neurocognitive and Affective Alterations." Pharmacology, Biochemistry, and Behavior 229 (2023): 173592. https://doi.org/10.1016/j.pbb.2023.173592.
MLA (9th ed.) CitationMT, Rodriguez, et al. "Therapeutically Targeting the Consequences of HIV-1-associated Gastrointestinal Dysbiosis: Implications for Neurocognitive and Affective Alterations." Pharmacology, Biochemistry, and Behavior, vol. 229, 2023, p. 173592, https://doi.org/10.1016/j.pbb.2023.173592.